CONMED Corporation
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $796.4M | $763.5M | $719.2M | $740.1M | $762.7M | $767.1M | $725.1M | $713.7M |
| Cost of Revenue | $365.4M | $355.2M | $337.5M | $336.0M | $350.3M | $361.3M | $350.1M | $348.3M |
| Gross Profit | $431.0M | $408.3M | $381.7M | $404.1M | $412.4M | $405.8M | $374.9M | $365.4M |
| Gross Margin | 54.1% | 53.5% | 53.1% | 54.6% | 54.1% | 52.9% | 51.7% | 51.2% |
| Operating Expenses | ||||||||
| Research & Development | $32.3M | $32.3M | $27.4M | $27.8M | $25.8M | $28.2M | $28.7M | $29.7M |
| SG&A Expense | $351.8M | $338.4M | $303.1M | $323.5M | $330.1M | $302.5M | $276.6M | $276.5M |
| Operating Income | $46.9M | $37.7M | $51.2M | $52.8M | $56.5M | $65.2M | $8.3M | $57.1M |
| Operating Margin | 5.9% | 4.9% | 7.1% | 7.1% | 7.4% | 8.5% | 1.1% | 8.0% |
| Interest Expense | $18.2M | $15.4M | $6.0M | $6.1M | $5.6M | $5.7M | $6.7M | $7.1M |
| Pretax Income | $28.7M | $19.4M | $45.1M | $46.7M | $50.6M | $59.5M | $-2.3M | $45.7M |
| Income Tax Expense | $-26.8M | $4.7M | $14.6M | $14.5M | $14.7M | $19.0M | $-3.1M | $15.3M |
| Net Income | $55.5M | $14.7M | $30.5M | $32.2M | $35.9M | $40.5M | $752.0K | $30.3M |
| Net Margin | 7.0% | 1.9% | 4.2% | 4.3% | 4.7% | 5.3% | 0.1% | 4.3% |
| EPS (Basic) | $1.99 | $0.53 | $1.10 | $1.17 | $1.30 | $1.43 | $0.03 | $1.06 |
| EPS (Diluted) | $1.97 | $0.52 | $1.09 | $1.16 | $1.28 | $1.41 | $0.03 | $1.05 |
| Shares Outstanding (Basic) | 27.9M | 27.8M | 27.7M | 27.4M | 27.7M | 28.3M | 28.2M | 28.7M |
| Shares Outstanding (Diluted) | 28.2M | 28.0M | 27.9M | 27.8M | 28.1M | 28.7M | 28.6M | 28.9M |
| Dividends Per Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.65 | $0.60 | $0.00 | $0.00 |